{
  "id": "30015a52e049785a",
  "title": "GSK plc : Exdensur ( depemokimab ) approved by US FDA for the treatment of severe asthma",
  "description": "20251217T033000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2025-12/67249977-gsk-plc-exdensur-depemokimab-approved-by-us-fda-for-the-treatment-of-severe-asthma-004.htm",
  "published_at": "20251217T033000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2025-12/67249977-gsk-plc-exdensur-depemokimab-approved-by-us-fda-for-the-treatment-of-severe-asthma-004.htm",
    "url_mobile": "",
    "title": "GSK plc : Exdensur ( depemokimab ) approved by US FDA for the treatment of severe asthma",
    "seendate": "20251217T033000Z",
    "socialimage": "https://www.finanznachrichten.de/chart-gsk-plc-aktie-intraday-xetra.png",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}